Related Experiment Video
Updated: May 31, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Non-Smad signaling pathways
Yabing Mu1, Shyam Kumar Gudey, Maréne Landström
1Medical Biosciences, Umeå University, SE-901 85 Umeå, Sweden.
Abstract:
Transforming growth factor-beta (TGFβ) is a key regulator of cell fate during embryogenesis and has also emerged as a potent driver of the epithelial-mesenchymal transition during tumor progression. TGFβ signals are transduced by transmembrane type I and type II serine/threonine kinase receptors (TβRI and TβRII, respectively). The activated TβR complex phosphorylates Smad2 and Smad3, converting them into transcriptional regulators that complex with Smad4. TGFβ also uses non-Smad signaling pathways such as the p38 and Jun N-terminal kinase (JNK) mitogen-activated protein kinase (MAPK) pathways to convey its signals. Ubiquitin ligase tumor necrosis factor (TNF)-receptor-associated factor 6 (TRAF6) and TGFβ-associated kinase 1 (TAK1) have recently been shown to be crucial for the activation of the p38 and JNK MAPK pathways. Other TGFβ-induced non-Smad signaling pathways include the phosphoinositide 3-kinase-Akt-mTOR pathway, the small GTPases Rho, Rac, and Cdc42, and the Ras-Erk-MAPK pathway. Signals induced by TGFβ are tightly regulated and specified by post-translational modifications of the signaling components, since they dictate the subcellular localization, activity, and duration of the signal. In this review, we discuss recent findings in the field of TGFβ-induced responses by non-Smad signaling pathways.
Insights
Transforming growth factor-beta (TGFβ) regulates cell fate and drives tumor progression via Smad and non-Smad pathways. This review highlights recent findings on TGFβ-induced non-Smad signaling, crucial for understanding cell fate and cancer.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor-beta (TGFβ) is a critical regulator of embryonic cell fate.
- TGFβ also drives the epithelial-mesenchymal transition (EMT) in tumor progression.
- TGFβ signaling involves transmembrane serine/threonine kinase receptors (TβRI and TβRII).
Purpose of the Study:
- To review recent findings on TGFβ-induced non-Smad signaling pathways.
- To elucidate the role of non-Smad pathways in TGFβ-mediated cellular responses.
- To highlight the regulation of TGFβ signaling by post-translational modifications.
Main Methods:
- Literature review of recent studies on TGFβ signaling.
- Analysis of Smad and non-Smad mediated pathways.
- Discussion of post-translational modifications in TGFβ signal transduction.
Main Results:
- TGFβ utilizes both Smad-dependent and Smad-independent (non-Smad) pathways.
- Key non-Smad pathways include MAPK (p38, JNK, Ras-Erk), PI3K-Akt-mTOR, and Rho GTPases.
- TRAF6 and TAK1 are crucial for activating p38 and JNK MAPK pathways.
- Post-translational modifications tightly regulate TGFβ signal duration and activity.
Conclusions:
- Non-Smad pathways are essential for conveying TGFβ signals.
- Understanding these pathways is critical for comprehending cell fate and cancer progression.
- Post-translational modifications play a vital role in TGFβ signal specificity and regulation.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways

